GJA1 and atrial fibrillation: In a rat model of AF induced by Ach-CaCl2, SLFM treatment significantly reduced markers related to atrial electrical remodeling, including the induction rate and duration of AF, while also alleviating fibrosis and the upregulation of Connexin 43 (Cx43) expression.